or Try an Advanced Search...

    Progressive Stocks List

    Symbol Grade Name % Change
    BIIB D Biogen Idec Inc. 0.23
    CHX D ChampionX Corporation 0.50
    EXEL F Exelixis, Inc. -1.51
    FULC F Fulcrum Therapeutics, Inc. -3.14
    GLTO F Galecto, Inc. -1.41
    ITT A ITT Corporation 0.63
    IGT F International Game Technology -2.22
    LRMR D Larimar Therapeutics, Inc. -0.67
    MIRM F Mirum Pharmaceuticals, Inc. -2.75
    View As Page of Charts
    Related Industries: Biotechnology Diversified Industrials Drug Manufacturers - Major Gambling Oil & Gas Equipment & Services
    Related Stock Lists: Biotechnology Medicine Cancer Disability Idiopathic Pulmonary Fibrosis Pulmonary Fibrosis Pump Acid Aerospace Components Aerospace Market Alcohol Alzheimer's Disease Artificial Lift Equipment Asset Integrity Management Ataxia Autoimmune Disorders Automation Technologies Bearings Bile Acid Bingo

    Related ETFs - A few ETFs which own one or more of the above listed Progressive stocks.

    Symbol Grade Name Weight
    PBE C PowerShares Dynamic Biotech & Genome 7.94
    BIS F ProShares UltraShort Nasdaq Biotechnology 6.85
    FBT C First Trust Amex Biotech Index Fund 6.8
    PXJ A PowerShares Dynamic Oil Services 5.11
    IBRN D iShares Neuroscience and Healthcare ETF 5.09
    View all Progressive ETFs...
    Compare ETFs
    Compare BIS to PXJ Compare FBT to PXJ Compare PBE to PXJ

        Progressive Stocks Recent News

        Date Stock Title
        May 17 BIIB Ionis, Biogen Down on Ending Development of ALS Drug
        May 17 FULC The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
        May 16 IGT IGT PlaySports Launches Trading Advisory Services in Michigan with Lac Vieux Desert Northern Waters Casino & Resort
        May 16 BIIB Biogen also drops collaboration with Ionis on Angelman syndrome candidate
        May 16 FULC Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
        May 16 BIIB Biogen and Ionis drop ALS candidate after trial setback
        May 16 BIIB Biogen, Ionis shelve ALS drug following study failure
        May 16 BIIB REFILE-UPDATE 2-Biogen, Ionis to discontinue development of experimental ALS drug
        May 16 BIIB Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
        May 16 BIIB Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
        May 16 CHX ChampionX declares $0.095 dividend
        May 16 CHX ChampionX Declares Quarterly Dividend
        May 15 BIIB Eisai projects major growth for Alzheimer's therapy Leqembi
        May 15 BIIB Biogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector
        May 15 BIIB Biogen Stock Continues Its 20% Sprint On A Twist In Alzheimer's Treatment
        May 15 FULC Wall Street Analysts See a 69.15% Upside in Fulcrum Therapeutics (FULC): Can the Stock Really Move This High?
        May 15 BIIB Eisai sets new revenue target for Alzheimer’s drug Leqembi
        May 15 BIIB Biogen partner Eisai begins FDA submissions for injectable Alzheimer’s therapy
        May 15 BIIB UPDATE 1-Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
        May 14 BIIB Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status
        Related Industries: Biotechnology Diversified Industrials Drug Manufacturers - Major Gambling Oil & Gas Equipment & Services
        Related Stock Lists: Biotechnology Medicine Cancer Disability Idiopathic Pulmonary Fibrosis Pulmonary Fibrosis Pump Acid Aerospace Components Aerospace Market Alcohol Alzheimer's Disease Artificial Lift Equipment Asset Integrity Management Ataxia Autoimmune Disorders Automation Technologies Bearings Bile Acid Bingo
        Progressive

        Browse All Tags